All stock reports

ASTRAZEN evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-28T11:25:38.621117+00:00

Metrics

latest_annual_period
2026-03-31
revenue
22755800000.0
net_income
1875200000.0
operating_cash_flow
68199999.0
free_cash_flow
32100000.0
total_assets
19891000000.0
total_liabilities
11163100000.0
total_equity
8727900000.0
cash
4486200000.0
total_debt
1106600000.0
revenue_growth
0.32819312550706536
earnings_growth
0.6201831691722828
net_margin
0.08240536478612046
roe
0.21485122423492478
debt_to_equity
0.1267888037213992
cash_conversion
0.036369453391638225
free_cash_flow_margin
0.0014106293780047285
trailing_pe
107.3514
forward_pe
102.0408
peg_ratio
Not supplied
price_to_book
23.4621
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-f4605fe68fa10c879bbed8a02df82c8191a5b1a77e82488a277a46ac36aa8358
Policy
stock-decisions-v1
Evidence bundle hash
07aa5cb4f48a7f58c3cd0dfaa4cb6a9fbcf0c433496cb40b014f8962b263738e
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 5390cb9505c62ab3b62ddead1dfc1d32e20d11c783d039ec2640e1103831d877
  • daily-price: a4b57f035553d2f9c1316a1b4e0d58ab4a0eb0a413f8e8f0fe80e433dac510aa
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 6031.00. The trailing 5-session price return was -8.50%. The trailing 20-session price return was -12.19%. The trailing 60-session price return was -25.59%. The trailing 250-session price return was -32.89%.

Risks

Average cached traded value over twenty sessions was INR 56,055,185. The closing price was -38.36% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.32819312550706536. The cached financial metric net margin is 0.08240536478612046. The cached financial metric roe is 0.21485122423492478. The cached financial metric debt to equity is 0.1267888037213992. The cached financial metric cash conversion is 0.036369453391638225.

Cached observations and evidence limits